CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX - News) and Fovea Pharmaceuticals, SA ("Fovea") announced today that they have entered into an exclusive license agreement for the ...
ROCHESTER, Minn., April 11 -- A simple test of ulnar fovea tenderness that led to discovery of a common type of ligament injury may ease diagnosis of unexplained wrist pain, researchers found. A ...
Genzyme and Paris-based Fovea Pharmaceuticals have forged a collaboration to develop gene therapies for blindness. The cross-Atlantic pact will match Genzyme's expertise in protein production and gene ...
ROCHESTER, Minn. - - A Mayo Clinic orthopedic surgeon has discovered a common cause of debilitating wrist pain - a split tear of the UT ligament - that can be reliably detected through a simple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback